Protocol 10559 "A Phase 2 Study of Erdafitinib in Patients with Recurrent or Progressive IDH-Wild Type Glioma with FGFR-TACC Gene Fusion," (NCT05859334)
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/cancer.jpg)
Details
Age
Adult
Locations
University of Colorado Hospital
Principal Investigator
![Photograph of Douglas Ney](https://som.ucdenver.edu/FIMS/Content/faculty/3341/CU-Doctors-3341.jpg)
Douglas Ney
Study ID
Protocol Number: 23-2578
More information available at ClinicalTrials.gov: NCT05859334
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers